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Children born very preterm are exposed to repeated neonatal procedures that induce
pain and stress during hospitalization in the neonatal intensive care unit (NICU). The
COMT Val158Met genotype is involved with pain sensitivity, and early life stress is
implicated in altered expression of methylation of the serotonin transporter. We examined:
(1) whether methylation of the serotonin transporter gene (SLC6A4) promoter differs
between very preterm children and full-term controls at school age, (2) relationships with
child behavior problems, and (3) whether the extent of neonatal pain exposure interacts
with the COMT Val158Met genotype to predict SLC6A4 methylation at 7 years in the
very preterm children. We examined the associations between the COMT genotypes,
neonatal pain exposure (adjusted for neonatal clinical confounders), SLC6A4 methylation
and behavior problems. Very preterm children had significantly higher methylation at 7/10
CpG sites in the SLC6A4 promoter compared to full-term controls at 7 years. Neonatal pain
(adjusted for clinical confounders) was significantly associated with total child behavior
problems on the Child Behavior Checklist (CBCL) questionnaire (adjusted for concurrent
stressors and 5HTTLPR genotype) (p = 0.035). CBCL Total Problems was significantly
associated with greater SLC6A4 methylation in very preterm children (p = 0.01). Neonatal
pain (adjusted for clinical confounders) and COMT Met/Met genotype were associated
with SLC6A4 promoter methylation in very preterm children at 7 years (p = 0.001). These
findings provide evidence that both genetic predisposition and early environment need to
be considered in understanding susceptibility for developing behavioral problems in this
vulnerable population.
Keywords: preterm, epigenetic, serotonin transporter, catechol-O-methyltransferase, methylation, pain, child,
premature
INTRODUCTION
Early life adversity and stress exposure are associated with alter-
ations in DNA methylation and changes in gene expression
(McGowan et al., 2009; Meaney, 2010; Bagot et al., 2012) and
importantly, such changes may be already taking shape long
before birth (Oberlander et al., 2008). DNA methylation is a crit-
ical epigenetic mechanism regulating gene expression and has
been suggested as a possible molecular mechanism explaining the
diversity in behavioral outcomes that follow exposure to early life
stressful events (Caspi et al., 2003; Rutter et al., 2006; McGowan
et al., 2009). DNA methylation offers a promising direction that
enables us to understand how exposure to adverse/stressful early
Abbreviations: NICU, neonatal intensive care unit; HPA, hypothalamic-pituitary-
adrenal axis; 5HTTLPR, serotonin-transporter-linked polymorphic region; CpG,
cystosine-guanosine dinucleotide pairs; DA, dopamine; COMT, catechol-O-
transferase; PFC, prefrontal cortex; PCA, principal component analysis; GZLM,
generalized linear modeling.
life events may lead to enduring changes in neuronal function
(Karsten and Baram, 2013).
Infants born very preterm [24–32 weeks gestational age (GA)]
spend weeks to months in the neonatal intensive care unit
(NICU) during a delicate and critical phase of very rapid brain
development, and programming of stress systems (Grunau et al.,
2004; Tu et al., 2007). In the NICU, these infants require
numerous invasive medical procedures to diagnose and treat life-
threatening conditions. This environment contrasts greatly from
the calm and protective maternal intrauterine environment, thus
exposing these fragile neonates to repeated highly stressful and
potentially painful experiences that are developmentally unex-
pected. Since stress and pain cannot be distinguished in immature
neonates, we have used the term “pain-related stress.” Despite
major improvement in the care of very preterm infants, rates
of neurodevelopmental problems in children born very preterm
do not appear to have improved, affecting about 50% of sur-
vivors (Gray et al., 2004; Aarnoudse-Moens et al., 2009). There are
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concerns regarding long-term consequences of pain-related stress
in very preterm neonates. Recent work from our group found that
procedural pain/stress exposure (controlling for clinical factors
related to prematurity, such as gestational age, postnatal infection,
cumulative morphine dose, days of mechanical ventilation, illness
severity on day 1, and number of surgeries) was associated with
altered gray and white matter maturation (Brummelte et al., 2012;
Ranger et al., 2013; Vinall et al., 2013a), corticospinal tract devel-
opment (Zwicker et al., 2013a,b), poorer motor (Zwicker et al.,
2013a), cognitive (Grunau et al., 2009; Doesburg et al., 2013),
and behavioral functioning in very preterm children (Vinall et al.,
2013b; Ranger et al., 2014). Moreover, greater cumulative expo-
sure to neonatal pain/stress has been associated with altered
developmental trajectory of stress hormone (cortisol) expres-
sion [i.e., programming of the hypothalamic-pituitary-adrenal
axis (HPA)] long after NICU discharge (Grunau et al., 2007,
2013; Miller et al., 2011). Examining the role of gene and envi-
ronment interactions is important to understand mechanisms
and the etiology of how early pain/stress contributes to altered
neurodevelopment in very preterm children.
We have taken a hypothesis-based targeted gene approach.
Two key stress and mood regulatory neurotransmitters and
related regulatory genes have been identified: serotonin and
dopamine. Serotonin is a widely distributed neurotransmitter
that appears early in gestation that plays a key role in early
brain development and later emotion, attention, cognition, and
learning during childhood (Lucki, 1998; Lesch, 2007; Weikum
et al., 2013). Central to the regulation of intrasynaptic serotonin
(5-hydroxytryptamine, 5HT) concentrations is the presynaptic
membrane-bound serotonin transporter protein (5HTT, encoded
by SLC6A4). Variants in the serotonin transporter promoter
region (5HTTLPR), are associated with altered gene expression
and 5HTT concentrations, and therefore have a critical role
in determining intrasynaptic serotonin signaling (Hanley and
Oberlander, 2012). The short (S) allele of 5HTTLPR results in
∼50% reduction in serotonin reuptake compared to the long (L)
allele (Heils et al., 1996). S allele carriers may have greater vul-
nerability for emotional disorders (Homberg and Lesch, 2011),
particularly in the context of early life stress (Caspi et al.,
2003) (recent reviews Serretti et al., 2007; Kuzelova et al., 2010).
Manipulations of 5HT signaling, either via pharmacologic 5HTT
blockade or SLC6A4 knock-out in mouse models, that increase
serotonin concentrations during developmentally sensitive peri-
ods, are associated with lasting behavioral, neurophysiological,
and neuroanatomical changes in animal models (Homberg et al.,
2010; Olivier et al., 2011; Simpson et al., 2011) and increased risk
for anxiety/depression symptoms in humans (Oberlander et al.,
2010; Weikum et al., 2013). It is well established that behav-
ioral problems such as attention deficit problems, internalizing
(depressive/anxiety symptoms), and to some extent externaliz-
ing (aggressive, hyperactivity symptoms) behaviors are preva-
lent in children born very preterm (Bhutta et al., 2002; Gray
et al., 2004; Aarnoudse-Moens et al., 2009). Recently, methy-
lation of the SLC6A4 promoter was shown to be associated
with early childhood adversity in adults with major depres-
sion (Kang et al., 2013). Therefore, examining the impact of
early life stress on changes in the methylation of the SLC6A4
promoter in very preterm children is likely to add to our under-
standing of how early changes in serotonin signaling might be
associated with altered neurodevelopmental outcomes differences
previously reported in this population compared to term born
counterparts.
Catechol-O-transferase (COMT) gene encodes for a key
enzyme in the metabolism of dopamine (DA), norepinephrine
(NE), and epinephrine (EPI) (Lotta et al., 1995). The Met/Met
genotype of theCOMT Val158Met variant is associated withmore
than a three- to four-fold decrease in COMT enzyme activity and
DA catabolism, which leads to an increase in DA availability and
reduced myelination (Lotta et al., 1995; Chen et al., 2004). This is
especially significant in the prefrontal cortex (PFC) where COMT
activity is the primary determinant of synaptic DA concentrations
(Garris and Wightman, 1994; Karoum et al., 1994). COMT vari-
ants have been associated with cognitive functions (Blasi et al.,
2005; Dumontheil et al., 2011); and mood disorders (Enoch et al.,
2003; Olsson et al., 2007; Aberg et al., 2011). For example, indi-
viduals with the Met allele are at increased risk for anxiety (Enoch
et al., 2003; Olsson et al., 2007).
Moreover, Zubieta and colleagues reported effects of the
COMT Val158Met genotype on µ-opioid system activation in
young adults, where individuals with the Met/Met genotype had
greater pain sensitivity and negative emotions to pain compared
to individuals with the Met/Val and Val/Val genotypes (Zubieta
et al., 2003). Further, the Val allele has been associated with
increased risk of schizophrenia in both European and Asian
populations (Fan et al., 2005), and decreased cognitive stabil-
ity (Bialecka et al., 2008). COMT and 5HTT have important
functional roles in regulating neurotransmission with mood and
behavior brain-related pathways, and given that both have func-
tional genetic variants, researchers have begun to investigate their
potential interaction in various pathologies (Olsson et al., 2007;
Radua et al., 2014).
Since both dopaminergic and serotonergic systems play a
critical role in mood regulation, there has been a considerable
amount of interest in their potential interactions. Drugs enhanc-
ing dopaminergic function such as buproprion are also effec-
tive antidepressants (Ascher et al., 1995). In rodents, exposure
of the striatum and nucleus accumbens to serotonin increased
dopamine release (review by Sasaki-Adams and Kelley, 2001).
Dopamine and serotonin systems also showed a significant degree
of convergence and plasticity in the rat medial prefrontal cortex
(Benes et al., 2000).
To further understand how early life stress exposure may con-
tribute to altered behavior in children born very preterm, this
study was undertaken to determine if methylation of SLC6A4 pro-
moter differed between very preterm children and full-term con-
trols at age 7 years. We hypothesized that methylation at school
age would be altered in those born very preterm due to the stress-
ful neonatal environment. We further explored whether child
behavioral problems, concurrent child stress level, and parental
factors were associated with differences in methylation. To inves-
tigate the effects of neonatal stress on child behavioral problems
and SLC6A4 methylation, in very preterm group only, we exam-
ined whether neonatal procedural pain exposure (adjusted for
clinical confounders) and/or concurrent stressors are associated
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with child behavioral problems at age 7 years. Finally, in very
preterm group only, we examined the effect of neonatal procedu-
ral pain exposure (adjusted for clinical confounders) and COMT
Val158Met genotype on SLC6A4 methylation at 7 years. Given
that COMT Val158Met genotype has been reported to be asso-
ciated with cognitive functions and pain sensitivity, we hypothe-
sized that the extent of early pain exposure would interact with
the COMT Val158Met genotype to affect SLC6A4methylation.
MATERIALS AND METHODS
PARTICIPANTS
Participants were part of a larger longitudinal study of long-
term effects of neonatal pain-related stress on brain, stress and
neurodevelopment of children born very preterm (24–32 weeks
gestation) (e.g., Grunau et al., 2007, 2009), who were admitted to
the level III NICU at Children’s and Women’s Health Centre of
British Columbia between 2000 and 2004. A total of 111 school
age children, 61 born very preterm and 50 born full-terms were
included in the current study [56 boys/55 girls; mean age 7.78 y
(±0.65) range 6.3–10.8 years]. Parents completed questionnaires
while children were undergoing psychometric testing.
All of the children had an IQ score above 70 on the Wechsler
Intelligence Scale for Children—4th Ed (Wechsler, 2003). None
had major cognitive, sensory, motor impairments, or was diag-
nosed with autism. We included in our sample three very preterm
children with intraventricular hemorrhage (IVH) grade 1 or 2,
and two grade 3 or 4, on neonatal ultrasound. This study was
approved by the Clinical Research Ethics Board of the University
of British Columbia and the Research Ethics Board of the B.C.
Children’s and Women’s Hospitals, and conforms to the conven-
tions set out in the Declaration of Helsinki. Written informed
consent was obtained from parents and assent from children.
NEONATAL DATA
Medical and nursing chart review of children born very preterm
was carried out by an experienced neonatal research nurse. The
data collection included but was not limited to, GA, birth weight,
illness severity on day 1 [Score for Neonatal Acute Physiology
(SNAP)- II (Richardson et al., 2001)], days of mechanical ven-
tilation, presence of culture proven infection, number of surg-
eries, and cumulative dose of morphine (Table 2). We quantified
neonatal pain-related stress as the number of skin-breaking pro-
cedures (e.g., heel lance, peripheral intravenous or central line
insertion, chest-tube insertion, and nasogastric tube insertion)
during the stay in the NICU, as previously reported (e.g., Grunau
et al., 2009; Brummelte et al., 2012). Each attempt at a proce-
dure was counted as one skin-break; all nursing staff in our NICU
have been trained to precisely record each attempt. Cumulative
morphine exposure was calculated as the average daily dose (i.e.,
intravenous dose plus intravenous-equivalent oral dose) adjusted
for daily body weight, multiplied by the number of daysmorphine
was administered.
MEASURES/ASSESSMENTS
Children completed the Wechsler Intelligence Scale for
Children—Fourth Edition (WISC-IV) (Wechsler, 2003).
A parent (110 mothers, 1 father) completed the following
questionnaires:
• Child Behavior Checklist (CBCL) for children ages 6–18
years (Achenbach and Rescorla, 2000), the most widely used
questionnaire for identifying problem behaviors in children.
Ratings are on a 3-point Likert scale [ranging from 0 (not
true) to 2 (very true or often true)] on 113 items regard-
ing child behavior in the past 6 months. The checklist
is comprised of eight syndrome scales (Anxious/Depressed,
Withdrawn/Depressed, Social Problems, Somatic Complaints,
Thought Problems, Attention Problems, Aggressive Behavior,
and Rule-Breaking Behavior) and two higher order-factors
of Internalizing and Externalizing Problems. Raw scores were
converted to age-standardized scores (T scores with mean= 50
and SD = 10) based on the normative samples of children for
age range separately by sex (Achenbach and Rescorla, 2000).
The Total Problems T-score was used as an indicator of overall
emotional and behavioral problems of the child, and yields an
alpha coefficient of 0.97 (Achenbach and Rescorla, 2000).
• The Beck Depression Inventory—2nd Editions (BDI-II) (Beck
et al., 1961) a 21-item self-report multiple-choice question-
naire widely used to assess the presence and severity of symp-
toms of depression, was used to evaluate parent depression.
The scale yields a single score that ranges from 0 to 63, with
higher scores indicating higher level of depression; reliability
alpha coefficient 0.92 (Gatewood-Colwell et al., 1989).
• The State-Trait Anxiety Inventory (Spielberger et al., 1983)
comprised of two separate 20-statement self-report scales: the
State-Anxiety scale to evaluate how respondents feel “right
now, at this moment” and the Trait-Anxiety scale how respon-
dents generally feel. Only the Trait Anxiety Scale was used
in the present study as an indicator of parent general anxi-
ety symptoms. Scores range from 20 to 80; reliability alpha
coefficient 0.86 (Spielberger et al., 1983).
HAIR CORTISOL
Cortisol was assayed from hair as an integrated measure of stress
level (HPA activity) in the previous 2 months following our pub-
lished protocol (Grunau et al., 2013; Vaghri et al., 2013). Hair
samples were collected from the vertex posterior of the head, as
this area has been shown to have the lowest coefficient of varia-
tion in hair cortisol concentrations (Sauve et al., 2007). A cluster
of hair strands (∼2–3mm diameter) was cut at the base of the
hair shaft from five small spots. The hair samples were secured
on a cardboard card with tape, labeled, and stored in individ-
ual sealed plastic bags at room temperature until analysis. The
most proximal 2 cm from the scalp of each hair sample was uti-
lized for the assay. Ten to 15mg from each hair sample was placed
in scintillation vials. To remove external contaminants, hair sam-
ples were washed twice by immersion in 3mL of isopropanol and
incubating at room temperature in a centrifuge at 100 rpm for
3min. After decanting the isopropanol, samples were allowed to
dry for at least 12 h. After drying, 1mL of methanol was added to
each scintillation vial. Hair was then finely minced with surgical
scissors. The vials were sealed with paraffin film and incubated
for 16 h at 50◦C in a centrifuge at 100 rpm. Following methanol
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extraction each cortisol-containing methanol solution was trans-
ferred into 5mL test tubes and evaporated on a test tube hot
plate under a steady stream of nitrogen gas. The residue was then
reconstituted with 250µL of phosphate buffered saline. These
reconstituted samples were analyzed using the salivary enzyme
linked immunoassay kit (Alpco Diagnostics, Salem, NH, USA).
The intra-assay and inter-day coefficients of variation were 8.9
and 5.1%, respectively. The kit reported a sensitivity of 1.0 ng/mL.
GENOTYPING
Genomic DNA was extracted from saliva using Oragene OG-
500 and prepIT-L2P collection kit (DNA Genotek/OraSure
Technologies Inc., Bethlehem, Pennsylvania). The COMT
Val158Met (rs4680) variant was genotyped using TaqMan SNP
Genotyping Assay reagents and an Applied Biosystems 7300 Real
Time PCR System (Applied Biosystems, Carlsbad, California).
Call rate was 100%. The Hardy-Weinberg equilibrium of allelic
distribution of the cohort was examined and compared to the
population distribution by chi-square test.
The L and S alleles of the 5HTTLPR serotonin transporter
variant was genotyped by polymerase chain reaction (PCR) with
the following primers stpr5, 5′-GGCGTTGCCGCTCTGAATGC
and stpr3, 5′-GAGGGACTGAGCTGGACAACCAC to generate
a 484-bp (S short allele) or a 528-bp (L long allele) product,
distinguished by agarose gel electrophoresis.
EPIGENETIC ANALYSIS
Using the DNA from saliva, the methylation status of a CpG-rich
region in the SLC6A4 promoter was quantified by bisulfite
Pyrosequencing (Dupont et al., 2004) as previously described
(Devlin et al., 2010). This region of the SLC6A4 promoter has
been reported to be differentially methylated and associated with
changes in SLC6A4 mRNA expression (Philibert et al., 2007,
2008; Devlin et al., 2010). Briefly, we have analyzed a region
of the SLC6A4 promoter between −479 and −350, relative to
the transcriptional start site, which contains 10CpG sites and
is adjacent to exon 1a (Devlin et al., 2010). Genomic DNA
was bisulfite-treated using the EZ DNA Methylation Gold Kit
(Zymo Research) following the manufacturer’s instructions and
stored at −20◦C until further analyzed. A 130 bp fragment of
the SLC6A4 promoter was amplified by PCR from bisulfite-
treated DNA using HotStar Taq DNA Polymerase (Qiagen) and
the following primers for SLC6A4: PMHSERTF, 5′-GTATTG
TTAGGTTTTAGGAAGAAAGAGAGA-3′ and PMHSERTR,
5′-AAAAATCCTAACTTTCCTACTCTTTAACTT-3′ (IDT Inc,
Coralville, IA), with the reverse primer containing a biotin at
the 5′ end. PCR products were purified and sequenced using a
PyroMark MD System (Biotage, Foxboro, MA) following the
manufacturer’s suggested protocol and the following sequencing
primer PMHSERTS, 5′-AAACTACACAAAAAAACAAAT-3′
(IDT). The percent methylation at each CpG site was quantified
using the Pyro Q-CpG software, version 1.0.9 (Biotage).
STATISTICAL ANALYSIS
T-tests were used to compare child characteristics between very
preterm and full-term groups. The number of skin-breaking
procedures was log-transformed and shown to be normally dis-
tributed by the Komogorov-Smirnov Normality Test. Percent
Methylation of the 10 SLC6A4CpG sites were arcsine transformed
to address the issue of heteroscedasticity (Lin et al., 2008; Laird,
2010). Principal component analysis (PCA) was used to reduce
the data in contrast to using the mean methylation of selected
CpG sites because of significant variances. This has been used by
others to examine SLC6A4 promoter methylation; the first PCA
factor had the largest possible variance and was extracted to repre-
sent the overall SLC6A4 promoter methylation of the 10 CpG sites
in the dataset (Beach et al., 2010). To examine the relationship
between COMT Val158Met genotypes and cumulative neona-
tal skin-breaking procedures (adjusted for clinical confounders),
generalized linear modeling (GZLM) was used. GLZM provides
an extension of general linear models and relaxes the requirement
of equality or constancy of variances that is required in tradi-
tional linear models. Statistical analyses were performed using
the Statistical Package for Social Sciences (SPSS) version 22 (IBM,
Somers, NY); p < 0.05 were considered statistically significant.
RESULTS
PARTICIPANT CHARACTERISTICS
Child and parent characteristics of 111 school-age children
(61 born very preterm; 50 born full-term) are summarized
in Table 1A. Parents of very preterm children had signifi-
cantly higher self-reported depression (on the Beck Depression
Inventory), compared to parents of full-term children (p = 0.02).
Children born very preterm (in this sample that excluded children
with low IQ or major brain injury and sensory-motor impair-
ments) showed a trend toward higher Total Problems on the Child
Behavior Check List completed by parents, compared to full-
terms (p = 0.055). Neonatal characteristics of the very preterm
children are shown in Table 1B. Genotype frequencies of COMT
Val158Met and the 5HTTLPR variant are shown in Table 2. Due
to the low frequencies of the S allele for 5HTTLPR, subjects with
homozygous S alleles (S/S) and the L/S genotype were grouped
together in all analyses. There were no significant differences in
genotype frequency between very preterm and full-term children,
and the distribution of 5HTTLPR and COMT Val158Met geno-
types had no significant discrepancy from the Hardy-Weinberg
equilibrium (p = 0.21 and p = 0.36 respectively).
SLC6A4 METHYLATION IN VERY PRETERM AND FULL-TERM CHILDREN
T-tests with correction for multiple comparisons were used to
compare the transformed methylation in the 10 SLC6A4 CpG
sites (CpG 1–10) between the very preterm and full-term groups.
Seven out of the 10 SLC6A4 CpG sites had significantly higher
methylation (CpG 1, 3–5, 8–10) and CpG 2 had lower methy-
lation in very preterm children compared to full-term children
(Table 3A). CpG 1–5 remained significant after correction for
multiple comparisons. Overall, at age 7 years, children born very
preterm had higher SLC6A4 methylation compared to children
born full-term.
PRINCIPAL COMPONENT ANALYSIS OF SLC6A4 METHYLATION
Principal component analysis (PCA) was used for data reduction.
Three principal components had an eigenvalue> 1, and together
they accounted for 57% of the total variance in SLC6A4methyla-
tion. Principal Component 1 (PC1) (eigenvalue = 3.2) explained
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32% of variance, while PC2 (eigenvalue = 1.4) and PC3 (eigen-
value = 1.1) explained 15 and 10% respectively. Loadings of the
CpG sites on the three components are shown inTable 3B. As PC1
was the predominant factor on the PCA, it was used to represent
Table 1A | Child and parent characteristics.
Very preterm Full-term p-Value
(N = 61) (N = 50)
mean (SD) mean (SD)
Child age (years) 7.7 (0.3) 7.9 (0.9) 0.090
Child hair cortisol (ng/ml) 2.33 (0.35) 2.38 (0.33) 0.468
Child CBCL total
problems T score
51.3 (10.4) 47.5 (10.0) 0.055
Child CBCL internalizing
behavior T score
51.3 (10.3) 50.3 (10.7) 0.616
Child CBCL externalizing
behavior T score
48.7 (9.6) 47.9 (10.3) 0.694
Parent BDI-II 6.9 (8.0) 4.0 (4.6) 0.020
Parent STAI trait anxiety 35.4 (9.7) 34.2 (8.3) 0.471
SD, standard deviation; CBCL, Child Behavior Check List; BDI-II, Beck
Depression Inventory 2nd edition; STAI, State Trait Anxiety Inventory.
Table 1B | Neonatal characteristics of children born very preterm.
Mean (SD) Range
Male (number, %) 36 (59)
Gestational age at birth (weeks) 28.2 (2.1) 25.0–32.9
Birth weight (g) 1134 (390) 520–2265
Skin-breaks 142 (89) 30–446
Cumulative morphine dose (mg) 2.27 (4.8) 0–22.9
Days of mechanical ventilation 16 (17) 1–58
Illness severity day I (SNAP-II) 15.7 (11.6) 0–45
Number of surgeries 0.5 (0.8) 0–3
Postnatal infection (number, %) 27 (44)
SD, standard deviation; SNAP-II, score for neonatal acute physiology (severity of
illness index).
Skin-breaks (i.e., neonatal pain-related stress) is equal to the number of skin-
breaking procedures from birth to term equivalent age or hospital discharge;
cumulative morphine dose is equal to daily morphine exposure adjusted for
daily weight; postnatal infection is counted as the presence of a culture proven
infection.
the most significant aspect of methylation in SLC6A4 CpG 1–10
in the present study.
To investigate the effects of neonatal pain-related stress on
child behavioral problems and SLC6A4 methylation, we exam-
ined the relationships between: (1) SLC6A4methylation and child
behavior problems; (2) number of neonatal skin-breaking pro-
cedures (adjusted for other neonatal factors) and child behavior
problems; and (3) number of skin-breaking procedures (adjusted
for other neonatal factors) and SLC6A4 methylation in very
preterm children.
SLC6A4 METHYLATION AND CHILD BEHAVIOR PROBLEMS
To investigate factors contributing to the altered SLC6A4 methy-
lation in very preterm children, GZLM analyses were then per-
formed separately in very preterm and full-term children to
determine the relationship with SLC6A4 methylation. Separate
analyses were conducted for very preterm and full-term chil-
dren since only the very preterm children were exposed to the
early adversity of procedural pain, therefore we expected different
relationships between the predictor variables and SLC6A4methy-
lation for each group. To build the group factor into the GZLM
would require adding too many interaction terms. The CBCL
Total Problems T score, concurrent parental depressive symptoms
(BDI II) and trait anxiety (STAI), hair cortisol concentration as
an index of cumulative stress level and perceived stress of the
child, and 5HTTLPR genotype (LL, LS, and SS) were entered
simultaneously as covariates to determine the effect on SLC6A4
methylation (Component 1 in PCA). 5HTTLPR genotype was
included as a covariate because it may contribute to SLC6A4
methylation differences (Beach et al., 2014). In very preterm chil-
dren, higher CBCL Total Problems score was significantly related
to greater SLC6A4methylation (r2 = 0.13; p = 0.01) after adjust-
ing for the other concurrent factors. For the full-term children,
since the Omnibus test was not statistically significant, there was
no further interpretation. Results of the GZLM are summarized
in Tables 4A,B.
COMT Val158Met was included in a separate model since this
genotype may be associated with emotion and behavior regula-
tion in children (Albaugh et al., 2010; Sheikh et al., 2013); the
COMT genotype had no significant relationship with methyla-
tion (p = 0.518). Also, alternative models were built separately
to examine whether CBCL Externalizing and Enternalizing T
scores were associated with SLC6A4 methylation. Before adjust-
ing for multiple comparisons Externalizing (p = 0.035) and
Table 2 | Allelic distribution of COMT and SERT genotypes.
Genotype Preterm Full-term Chi-squarep-valuea Hardy-Weinberg equilibriump-valueb
SERT 5HTTLPR LL 19 10 0.17 0.21
LS +SS 41 40
COMT rs4680 (C_25746809_50) GG Val/Val 20 13 0.78 0.36
AG Val/Met 30 26
AA Met/Met 10 9
ap-Values from Pearson Chi-Square tests between preterm and full-term children.
bp-Values from Hardy-Weinberg Equilibrium between allelic distributions.
L, Long allelic variant of SLC6A4 promotor; S, Short allelic; SERT, serotonin promoter gene; COMT, Catechol-O-methyltransferase.
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Table 3A | SLC6A4 percent methylation in preterm and full-term
children.
SLC6A4 Preterm Full-term p-Value**
CpG sites (N = 61) (N = 50)
mean (SD*) mean (SD)
CpG 1 3.79 (0.92) 3.15 (0.72) <0.0001†
CpG 2 1.60 (0.66) 2.00 (0.44) <0.0001†
CpG 3 4.96 (1.06) 4.17 (0.74) <0.0001†
CpG 4 1.79 (0.60) 1.32 (0.52) 0.001†
CpG 5 4.06 (0.87) 2.69 (0.69) <0.0001†
CpG 6 1.49 (0.60) 1.62 (0.43) 0.142
CpG 7 2.87 (0.75) 2.93 (0.70) 0.777
CpG 8 3.48 (0.88) 3.09 (0.65) 0.009
CpG 9 3.52 (0.81) 3.11 (0.73) 0.008
CpG 10 6.08 (1.43) 5.42 (1.23) 0.017
*SD, standard deviation of % methylation.
**p-Values of t-tests of the arcsine transformed SLC6A4 methylation [sin−1
(% methylation/100)1/2] between the preterm and full-term groups.
†Significant after controlled for multiple comparisons by Bonferroni correction.
Table 3B | PCA component loadings of 10 CpG sites.
SLC6A4 CpG sites Component 1 Component 2 Component 3
CpG 1 0.653 −0.120 0.018
CpG 2 −0.107 0.746 0.247
CpG 3 0.591 −0.029 0.404
CpG 4 0.541 −0.466 0.217
CpG 5 0.763 −0.408 0.031
CpG 6 0.031 0.225 0.801
CpG 7 0.527 0.453 −0.185
CpG 8 0.624 0.142 −0.018
CpG 9 0.748 0.269 −0.174
CpG 10 0.546 0.372 −0.278
CA, principal component analysis.
Component 1 (eigenvalue = 3.2) explained 32% of variance.
Component 2 (eigenvalue = 1.4) explained 14% of variance.
Component 3 (eigenvalue = 1.1) explained 11% of variance.
Internalizing (p = 0.077) were marginally significant, however
neither was significant after adjusting for multiple comparisons
of Externalizing and Internalizing scores.
NEONATAL PAIN AND CHILD BEHAVIOR PROBLEMS
To further advance our understanding of neonatal pain in relation
to child behavior problems at 7 years, GZLM was used to investi-
gate the association with CBCL Total Problems T score. Predictors
were neonatal pain (cumulative skin breaking procedures from
birth to term equivalent age) adjusted for clinical confounders
related to prematurity (GA at birth, number of days on mechan-
ical ventilation, illness severity on day 1 [SNAP-II], number of
surgeries, presence of culture proven infection, cumulative dose of
morphine), and concurrent parental depressive symptoms (BDI
II) and trait anxiety (STAI), and child stress level (hair corti-
sol) as covariates. Greater neonatal pain (after adjustment for
Table 4A | Generalized linear modeling analysis to predict SLC6A4
methylation in very preterm children.
Parameter Ba Std. error 95% confidence p-Value
interval
Lower Upper
CBCL total problems
T-score
0.042 0.0161 0.010 0.074 0.010
Child hair cortisol
level
0.024 0.4018 −0.764 0.811 0.953
Parent BDI-II −0.037 0.0293 −0.094 0.020 0.207
Parent STAI trait
anxiety score
0.023 0.0216 −0.020 0.065 0.295
Child 5HTTLPR LL 0.577 0.3048 −0.020 1.175 0.058
Omibus test: p = 0.035.
GZLM results showing CBCL Total Problem T-score (adjusted for concurrent
stressors, hair cortisol, and 5HTTLPR genotype) associated with SLC6A4 methy-
lation in children born very preterm.
Model: SLC6A4 methylation = CBCL Total Problem T-score + Child hair cortisol
+ BDI-II + STAI anxiety + 5HTTLPR genotypes.
aUnstandardized regression coefficient.
CBCL, Child Behavior Check List; BDI-II, Beck Depression Inventory 2nd edition;
STAI, State Trait Anxiety Inventory; L, Long allelic variant of SLC6A4 promotor;
S, Short allelic.
Table 4B | Generalized linear modeling analysis to predict SLC6A4
methylation in full-term children.
Parameter Ba Std. error 95% confidence p-Value
interval
Lower Upper
CBCL total problems
T-score
0.040 0.0190 0.003 0.077 0.036
Child hair cortisol
level
0.316 0.4928 −0.649 1.282 0.521
Parent BDI-II 0.027 0.0444 −0.060 0.113 0.550
Parent STAI trait
anxiety score
−0.023 0.0272 −0.076 0.031 0.406
Child 5HTTLPR LL 0.377 0.3951 −0.398 1.151 0.340
Omibus test: p = 0.314.
GZLM results showing CBCL Total Problems T-score (adjusted for concurrent
stressors, hair cortisol, and 5HTTLPR genotype) associated with SLC6A4 methy-
lation in children born very preterm.
Model: SLC6A4 methylation = CBCL Total Problems T-score + Child hair cortisol
+ BDI-II + STAI anxiety + 5HTTLPR genotypes.
aUnstandardized regression coefficient.
CBCL, Child Behavior Check List; BDI-II, Beck Depression Inventory 2nd edition;
STAI, State Trait Anxiety Inventory; L, Long allelic variant of SLC6A4 promotor;
S, Short allelic.
all covariates) was associated with higher Total Problems score
on the Child Behavior Checklist (CBCL) (p = 0.035, r2 = 0.39).
5HTTLPR and COMT genotypes were then added in subsequent
models and were not significant (p = 0.866). GZLM results are
summarized in Table 5.
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Table 5 | Generalized linear modeling analysis of CBCL Total Problems
T scores predicted by neonatal pain-related stress.
Parameter Ba Std. error 95% confidence p-Value
interval
Lower Upper
Skin-breaks 17.99 8.54 1.25 34.73 0.035
Neonatal infection 3.80 2.89 −1.86 9.47 0.188
Cumulative
morphine dose
8.88 6.41 −3.68 21.44 0.166
Days of ventilation −0.04 0.16 −0.35 0.27 0.779
SNAP-II day 1 0.14 0.12 −0.11 0.38 0.279
Number of surgery −2.24 1.93 −6.03 1.55 0.246
Gestational age (GA) 2.93 0.88 1.21 4.65 0.001
Child hair cortisol
level
2.18 3.36 −4.40 8.76 0.516
Parent BDI-II 0.56 0.25 0.07 1.06 0.025
Parent STAI trait
anxiety score
−0.01 0.18 −0.37 0.35 0.959
GZLM results showing CBCL Total Problems T scores was predicted by neonatal
pain-related stress.
Model: CBCL Total Problems T scores = skin-breaks + Infection + morphine
exposure + days of ventilation + SNAP-II + surgery + GA + Child hair cortisol
+ BDI-II + STAI anxiety.
aUnstandardized regression coefficient.
SNAP-II, score for neonatal acute physiology (severity of illness index).
Skin-breaks (i.e., neonatal pain-related stress) is equal to the number of skin-
breaking procedures from birth to term equivalent age or hospital discharge;
cumulative morphine dose is equal to daily morphine exposure adjusted for
daily weight; postnatal infection is counted as the presence of a culture proven
infection.
EFFECT OF NEONATAL PAIN AND COMT Val158Met GENOTYPES ON
SLC6A4 METHYLATION IN VERY PRETERM CHILDREN
To test our hypothesis that neonatal pain would interact with
COMT Val158Met genotype to affect SLC6A4methylation (PC1),
a GZLM model was built, in the very preterm group only,
with neonatal pain (cumulative skin breaking procedures from
birth to term equivalent age) and COMT Val158Met genotypes
(Val/Val, Val/Met, Met/Met), and clinical confounders related
to prematurity (GA, number of days on mechanical ventila-
tion, SNAP-II day 1, number of surgeries, presence of culture
proven infection, cumulative dose of morphine) as covariates.
All variables and interactions were entered simultaneously in the
model. GZLM results are summarized in Table 6. There was a
significant interaction between COMT Val158Met genotype and
neonatal pain after adjusting for clinical confounders. Greater
number of skin breaking procedures (independent of these
covariates) was significantly associated with lower overall SLC6A4
methylation (PC1 of PCA) in children with COMT Met/Met
genotype (r2 = 0.46, p = 0.001). This interaction is illustrated
in Figure 1. Concurrent parental depressive symptoms (BDI-
II) and trait anxiety (STAI), hair cortisol level, and 5HTTLPR
variants were included in a further model and none of them
yielded significant results (p = 0.330, 0.062, 0.142, and 0.388
respectively).
Table 6 | Generalized linear modeling analysis of SLC6A4 methylation
predicted by COMT genotype and neonatal pain-related stress.
Parameter Ba Std. error 95% confidence p-Value
interval
Lower Upper
COMT Val/Val ×
Skin-breaks
−0.401 1.3908 −3.127 2.325 0.773
COMT Val/Met ×
Skin-breaks
1.550 0.9558 −0.324 3.423 0.105
COMT Met/Met ×
Skin-breaks
−5.634 1.6642 −8.896 −2.373 0.001
COMT Val/Val −10.012 4.0286 −17.908 −2.116 0.013
COMT Val/Met −14.469 3.4845 −21.298 −7.639 0.000
Neonatal infection 0.542 0.3137 −0.073 1.157 0.084
Cumulative
morphine dose
−0.237 0.7364 −1.681 1.206 0.747
Days of ventilation 0.006 0.0153 −0.024 0.036 0.710
SNAP-II day 1 0.016 0.0132 −0.010 0.042 0.216
Number of surgery −0.007 0.2234 −0.445 0.431 0.976
Gestational age (GA) 0.150 0.1057 −0.057 0.357 0.155
GZLM results showing SLC6A4 methylation was predicted by COMT genotype
and neonatal pain-related stress.
Model: SLC6A4 Methylation = (COMT genotype × skin-breaks) + Infection +
COMT genotype + skin-breaks + morphine exposure + days of ventilation +
SNAP-II + surgery + GA.
aUnstandardized regression coefficient.
SNAP-II, score for neonatal acute physiology (severity of illness index).
Skin-breaks (i.e., neonatal pain-related stress) is equal to the number of skin-
breaking procedures from birth to term equivalent age or hospital discharge;
cumulative morphine dose is equal to daily morphine exposure adjusted for
daily weight; postnatal infection is counted as the presence of a culture proven
infection.
DISCUSSION
This is the first study, to our knowledge, to demonstrate that chil-
dren born very preterm have higher SLC6A4 promoter methyla-
tion compared to full-term children. Previous studies have shown
effects of early life adversity on overall higher methylation in
SLC6A4 promoter in adults who were adopted in infancy (Beach
et al., 2010) and in patients with major depression (Kang et al.,
2013) and bipolar disorder (Sugawara et al., 2011; Zhao et al.,
2013). Moreover, our findings suggest that the stress of repeated
invasive procedures that very preterm infants are exposed to while
in the NICU during the first weeks to months of life may be one
of the contributing factors affecting SLC6A4 methylation in the
very preterm children at entry to school age. However, SLC6A4
methylation was reported to be related to various other con-
current environmental stressors (Zhao et al., 2013). Therefore,
in the present study we examined and adjusted for potential
effects of concurrent stressors while investigating effects of early
pain-related stress on SLC6A4methylation at age 7 years.
We found that in very preterm (but not full-term) children,
higher methylation of the SLC6A4 promoter region at age 7 years
was associated with overall child behavior problems, after adjust-
ing for concurrent parent stressors, child cumulative cortisol level,
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FIGURE 1 | Greater neonatal pain-related stress was associated with
lower SLC6A4 promoter methylation in very preterm children with
COMT Met/Met genotype.
and the child 5HTTLPR genotype. The CBCL Total Problems T
score was used as an index of overall emotional and behavioral
problems of the child (Achenbach and Rescorla, 2000), and is
associated with both concurrent and life time exposure to envi-
ronmental stress (Compas et al., 1989). The children’s higher
order-factors of internalizing and externalizing problems were
not independently found to be related to SLC6A4 methylation
after adjusting for multiple comparisons. Again, the fact that the
adjusted CBCL Total Problems scores were related to the over-
all SLC6A4 methylation only in very preterm children suggests
a unique pathway to altered SLC6A4 methylation in these chil-
dren. We then identified that among the neonatal factors to which
only the preterm infants are exposed, greater procedural pain
exposure was associated with higher child behavior problems
after controlling for concurrent stressors and 5HTTLPR geno-
type. As has been established in the literature, lower gestational
age (Loe et al., 2011) and maternal depression (Beck, 1999) both
are associated with behavior problems in children. Importantly,
early adversity of repeated pain-related stress early in life pre-
dicted child behavior problems above and beyond these other
risk factors. In the same cohort of very preterm children, we
have previously reported that greater neonatal procedural pain-
related stress exposure was associated with higher internalizing
behaviors at 18 months and at school age (Vinall et al., 2013b;
Ranger et al., 2014), after accounting for similar clinical factors
related to prematurity. In the present study we focused on explor-
ing the relationship between neonatal pain (adjusted for clinical
confounders) and SLC6A4 methylation within the very preterm
group in an attempt to further advance our understanding of
possible mechanisms that could explain the relationship between
prematurity and child behavioral problems.
In children born very preterm we found that greater neona-
tal pain (adjusted for clinical confounders) was significantly
associated with lower methylation, however this was only seen in
those children with the COMT 158 Met/Met genotype. Previous
studies in healthy adults have reported that homozygosity for
the COMT 158 Met-allele was associated with greater pain sen-
sitivity compared to individuals with the Met/Val and Val/Val
genotypes (Zubieta et al., 2003). Therefore, it is possible that
the COMT 158 Met/Met genotype may be more susceptible
(or vulnerable) to neonatal pain. The lower SLC6A4 methy-
lation in children with the Met/Met genotype may reflect a
stress-sensitive genetic variation by which the already height-
ened response to early life stress/pain of these children was
biologically reduced. Accordingly, it appears that COMT 158,
a key dopamine-regulatory allele, may contribute to vulnerabil-
ity or resilience to early life procedural stress during a period
of physiological immaturity. However, in the current study, it
is not possible to determine the functional effects of SLC6A4
methylation and whether increases or decreases in SLC6A4
methylation have positive or negative implications during child-
hood. Given that the COMT Val158Met genotype (Met/Met)
differentially interacted with early exposure to neonatal pain
to affect subsequent methylation of SLC6A4, we speculate that
lower SLC6A4 methylation in very preterm children with the
COMT 158 Met/Met genotype suggests a possible resiliency or
protective mechanism for children who are exposed to early
stress (Armbruster et al., 2012). One possible explanation is
the increased cognitive stability linked to COMT 158 Met-allele
as reported previously in infants (Markant et al., 2014), chil-
dren (Diamond et al., 2004), and adults (Barnett et al., 2007).
According to the tonic/phasic dopamine theory, Met allele may
enhance tonic dopamine while Val enhances phasic dopamine.
Phasic dopamine may be important updating working mem-
ory traces, via D2 receptors, while tonic dopamine may enhance
stability of traces, via D1 receptors (Cohen et al., 2002). The
sustained D1 activation (tonic dopamine) helps prevent “uncon-
trolled, spontaneous activation of task-irrelevant representation,”
(Durstewitz et al., 2000; Durstewitz and Seamans, 2002) and
may function as a buffer against stressful early environment
(Bilder et al., 2004).
The present study investigated the methylation status of the
SLC6A4 promoter from saliva samples, since serotonergic neu-
rons cannot be examined (Durstewitz and Seamans, 2002).
Previous studies have found relationships between blood DNA
methylation and mental disorders such as depression (Philibert
et al., 2007; Devlin et al., 2010; Ghadirivasfi et al., 2011; Nohesara
et al., 2011). Genome-wide methylation study revealed the DNA
methylation levels between blood and postmortem brain tissues
to be highly correlated (r = 0.90) (Horvath et al., 2012). Another
genome-wide DNA methylation study has shown that DNA from
white blood cells and saliva have 97% of genes with similar
methylation patterns, and saliva samples consistently had lower
methylation levels than blood samples (Thompson et al., 2013).
Also, methylation ofMB-COMT fromDNA in postmortem brain
tissues and saliva were found to be closely related (Nohesara et al.,
2011). Therefore, our use of saliva methylation status is justi-
fied. In this study, the overall methylation differences between
full-term and very preterm children were small but the relative
percentage differences between the groups were in the same range
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as found by others in different populations (e.g., Devlin et al.,
2010; Kang et al., 2013).
Our findings suggest that the highly stressful environment
of repeated exposure to procedural pain-related stress that very
preterm infants undergo during their stay in the NICU appears to
be one of the factors contributing to the higher SLC6A4 methy-
lation and greater behavioral problems at school-age in children
born very preterm, compared to full-term. Through their pro-
longed hospitalization during a vulnerable period of physiological
immaturity, very preterm neonates are exposed to multiple fac-
tors that appear to alter their neurodevelopmental trajectory, and
teasing out specific pain-related effects is challenging. There are
other factors such as prenatal parent mental health that may
impact prematurity itself, as well as methylation status of off-
spring. Prenatal and postnatal clinical factors, treatments, and
genetic variation might interact or may lead to similar end points,
which makes them difficult to isolate (Grunau et al., 2013; Ranger
et al., 2014). Future studies are needed to evaluate whether inter-
ventions to manage neonatal pain may ameliorate long-term
epigenetic changes in very preterm infants.
CONCLUSION
This study suggests that early repeated procedural pain-related
stress exposure is associated with altered methylation of the
SLC6A4 promoter in children born very preterm, but only among
individuals with the COMT 158 Met/Met genotype. We found a
complex relationship between epigenetic modifications, COMT
Val158Met genotype and early exposure to highly stressful envi-
ronmental events that induce pain in children born during a
critically sensitive developmental period. These findings may
indicate that preterm infants with the COMT Val158Met geno-
type experience pain differently and as a result the long term
biological impact of early pain-stress differ and could have
implications for subsequent serotonin signaling. These find-
ings begin to address mechanisms underlying pathways lead-
ing to behavioral problems or resiliency in this vulnerable
population.
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